PSNL 3.3 (-7.3%)
US71535D1063Medical Diagnostics & ResearchDiagnostics & Research

Personalis (PSNL) Competitor Comparison

We are evaluating the key criteria listed to compare Personalis (PSNL) against its competitors in the Diagnostics & Research industry.

Performance 5 years - PSNL ranking 35 / 58

These are the competitors of Personalis in the industry Diagnostics & Research ranked by performance 5 years
1. Lantheus Holdings LNTH
808.93
2. Natera NTRA
526.14
3. RadNet RDNT
503.55
4. Medpace Holdings MEDP
374.58
5. Laboratory Corp of America Holdings LH
155.63
6. IDEXX Laboratories IDXX
131.36
7. Quest Diagnostics DGX
125.64
8. Meridian Bioscience VIVO
118.46
9. Waters WAT
110.55
10. IQVIA Holdings IQV
102.05
11. Thermo Fisher Scientific TMO
90.17
12. Fulgent Genetics FLGT
89.26
13. Mettler-Toledo MTD
85.66
14. Agilent Technologies A
80.76
15. Twist Bioscience TWST
76.07
16. Danaher DHR
75.37
17. Anixa Biosciences ANIX
65.45
18. DarioHealth DRIO
61.4
19. Charles River Laboratories CRL
60.74
20. Icon ICLR
53.71
21. PerkinElmer PKI
48.44
22. DexCom DXCM
40.87
23. Ortho Clinical Diagnostics Holdings OCDX
13.74
24. Heska HSKA
12.14
25. CareDx CDNA
10.46
26. Co-Diagnostics CODX
6.45
27. Qiagen QGEN
5.03
28. Exact Sciences EXAS
-9.38
29. Inotiv NOTV
-10.13
30. Syneos Health SYNH
-16.98
31. Myriad Genetics MYGN
-21.49
32. Olink Holding OLK
-26.82
33. Guardant Health GH
-27.97
34. Bioventus BVS
-36.09
35. Personalis PSNL
-49.07
36. Pacific Biosciences of California PACB
-50.94
37. Precipio PRPO
-51.57
38. Sotera Health SHC
-55.93
39. Psychemedics PMD
-60.54
40. NeoGenomics NEO
-61.51
41. Illumina ILMN
-62.4
42. National Research NRC
-63.6
43. Enzo Biochem ENZ
-65.26
44. Neogen NEOG
-69.29
45. Sera Prognostics SERA
-74.75
46. Exagen XGN
-75.7
47. Trinity Biotech TRIB
-81.02
48. MaxCyte MXCT
-81.81
49. Global Cord Blood CO
-86.47
50. Interpace Biosciences IDXG
-86.51
51. MDxHealth MDXH
-86.83
52. bioAffinity Technologies BIAF
-88.45
53. Neuronetics STIM
-92.42
54. Biodesix BDSX
-92.64
55. Aspira Womens Health AWH
-92.98
56. Organovo Holdings ONVO
-95.1
57. SeqLL SQL
-95.22
58. Prenetics Global PRE
-96.61

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.